-
Clinical trial tests new imaging method for metastatic prostate cancer
-
Clinical trial tests a PARP inhibitor in urothelial cancer
-
African Postdoctoral Training Initiative fellow looks forward to collaborating with NCI
-
Lab-based study identifies mutations that allow HIV-1 to escape antiretroviral therapy
-
MEK inhibitor selumetinib granted breakthrough designation by FDA to treat NF1 in pediatric patients
-
We are in search of a chief to lead the Structural Biology Laboratory on our Frederick, Maryland campus. For more i… https://t.co/8gJ5N86Isc
-
RT @apolo_andrea: We could not do #CancerResearch without our fabulous administrators Thank you Carlos and Tammy!… https://t.co/EKjO8FZVRr
-
RT @TheChildrensInn: "Even if they don't find a cure for me, and a kid in the future has the same disease as me or anything close, if th… https://t.co/Go2rpU2HMi
-
RT @FredNatLab: Discover how #imaging #technology elevates #cancer #biology at #FredNatLab & #hood_college science symposium Jun 21… https://t.co/gBvQYOsXUw
-
Today we honored our support staff with a small gathering. Thanks to all of you for your hard work and dedication!… https://t.co/hT6IRMVDZ1
-
Gender disparity in HCC: Is it the fat and not the sex? Nice review from Tim Greten #LiverCancer https://t.co/C97ROMxxAO
-
RT @NCIEpiTraining: This week is #WorldImmunizationWeek. DCEG investigators have tested the efficacy of the #HPV vaccine for the preven… https://t.co/s7JSYiAe0x
